ATXI AVENUE THERAPTC
-
AVENUE THERAPTC Reported Earnings
Friday, November 6, 2026 · 12:00 AM ET
AVENUE THERAPTC (ATXI) reported a loss of $0.20 per share on revenue of $0.00 million for the . .
Avenue Therapeutics, Inc. is a specialty pharmaceutical company. It acquires, licenses, develops and commercializes products principally for use in the acute/intensive care hospital setting. Avenue Therapeutics, Inc. is based in New York, United States.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
($0.20)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth
Reported Revenue
—
Revenue Estimate
—
Revenue Surprise
Revenue Growth—